Literature DB >> 20472267

Endourological treatment of nonmalignant upper urinary tract complications after urinary diversion.

Ahmed R El-Nahas1, Ahmed A Shokeir.   

Abstract

Endourological modalities are considered the first line of treatment for benign ureterointestinal anastomotic strictures except in long strictures, completely obliterated lumen, prior radiation, and poor renal function. Endoureterotomy provided better success than balloon dilatation. In poor-operative risk patients, metal or double-J stents are viable options. Endourological treatments of upper tract stones after diversion are indicated for stones not suitable for shock wave lithotripsy (SWL) or to salvage SWL failure. Percutaneous nephrolithotomy was preferred for large or complex renal stones, whereas ureteroscopy was used for smaller stones. The evaluation of stone-free status and regular follow-up are mandatory because of the high recurrence rate.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20472267     DOI: 10.1016/j.urology.2010.03.014

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  CUA Guideline: Management of ureteral calculi.

Authors:  Michael Ordon; Sero Andonian; Brian Blew; Trevor Schuler; Ben Chew; Kenneth T Pace
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

Review 2.  Treatment of upper urinary lithiasis in patients who have undergone urinary diversion.

Authors:  Gina M Badalato; Janice A Santos Cortes; Mantu Gupta
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

3.  Risk factors for urinary infection after retrograde upper urinary lithotripsy: Implication for nursing.

Authors:  Chuan Peng; Zhaozhao Chen; Jun Xu
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

4.  Endourologic strategies for a minimally invasive management of urinary tract stones in patients with urinary diversion.

Authors:  FangLing Zhong; Gurioli Alberto; GuangMing Chen; Wei Zhu; FuCai Tang; Guohua Zeng; Ming Lei
Journal:  Int Braz J Urol       Date:  2018 Jan-Feb       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.